首页 > 市场调查报告书 > 製药

感染疾病

市场调查报告书

商品编码

1084759

头孢菌素药的市场规模、占有率、趋势、预测 (2022年～2028年):各世代、类型、製剂、适应症、流通管道、地区

Cephalosporin Drugs Market, By Generation, By Type, By Formulation, By Indication, By Distribution Channel, and By Region - Size, Share, Trends, and Forecast, 2022 - 2028

出版日期: 2022年05月06日 | 出版商:

Coherent Market Insights | 英文 236 Pages | 商品交期: 2-3个工作天内

价格

简介目录

呼吸系统感染疾病的全球流行支援头孢菌素药市场成长。

本报告提供全球头孢菌素药的市场调查，市场定义和概要，市场成长的各种影响因素分析，偿付情境，开发平台的分析，市场规模的变化、预测，各种区分、各地区/主要国家的明细，竞争环境，主要企业简介等彙整资讯。

Cephalosporin drugs are a group of broad-spectrum, semi-synthetic beta-lactam antibiotics generally used for the treatment of bacterial infections such as bacterial meningitis, otitis media, pneumonia, tuberculosis, upper respiratory tract infection, eye infections, sinusitis, urinary tract infections, skin infections, and sexually transmitted diseases. Most commonly used cephalosporin are cephalexin, ceftriaxone, cefixime, cefdinir, and cefaclor. The cephalosporin drugs market holds a huge potential in the sub-Saharan countries of Africa such as Ethiopia, Ghana, Nigeria, and Senegal, as these countries have high prevalence of bacterial infections due to underdeveloped healthcare facilities and infrastructure. For instance, according to the World Health Organization's (WHO) report of February 2021, the highest burden of this disease is in the belt of sub-Saharan Africa, stretching from Senegal in the west to Ethiopia in the east. Around 30,000 cases are still reported each year from that area.

Market Dynamics

Increasing prevalence of respiratory tract infections worldwide is expected to boost the cephalosporin drugs market growth. For instance, according to the report of The Global Impact of Respiratory Disease in 2017, lower respiratory tract infection and pneumonia are two of the leading causes of death, accounting for over 4 million fatalities, annually. Furthermore, pneumonia killed 920,136 children aged under 5 years in 2015, accounting for 15% of the deaths in this age group. Streptococcus pneumoniae remains the most frequent bacterial cause of pneumonia, accounting for deaths of 393,000 children aged under 5 years in 2015.

However, factors such as increasing Food and Drug Administration (FDA) recalls is hindering the cephalosporin drugs market growth. For instance, in June 2019, Lupin Limited recalled 18,604 bottles (60 ml) of Cefdinir (Cephalosporin) for Oral Suspension, used for the treatment of bacterial infections, from the U.S. market. Furthermore, in January 2019, the company announced recall of 287,784 bottles of Cefdinir for Oral Suspension in the U.S. due to CGMP (Current Good Manufacturing Practice) deviations.

Key features of the study:

This report provides in-depth analysis of the cephalosporin drugs market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cephalosporin drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include, Merck & Co. Inc., GlaxoSmithKline plc., Pfizer Inc., Allergan plc., Abbott Laboratories, Basilea Pharmaceutica Ltd., Sanofi S.A., F. Hoffmann-La Roche AG, Lupin Limited, Teva Pharmaceutical Industries Ltd., and B. Braun Melsungen AG
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global cephalosporin drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for cephalosporin drugs market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Cephalosporin Drugs Market, By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
Global Cephalosporin Drugs Market, By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
Global Cephalosporin Drugs Market, By Formulation:
- Oral
  - Tablets
  - Capsules
  - Liquid
- Injection
Global Cephalosporin Drugs Market, By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
Global Cephalosporin Drugs Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Cephalosporin Drugs Market, By Region:
- North America
  - By Country:
- U.S.
- Canada
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Europe
  - By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Asia Pacific
  - By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Latin America
  - By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Middle East
  - By Country:
- GCC
- Israel
- Rest of Middle East
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Africa
  - By Country/Region:
- South Africa
- Central Africa
- North Africa
  - By Generation:
- First-generation Cephalosporin
- Second-generation Cephalosporin
- Third-generation Cephalosporin
- Fourth-generation Cephalosporin
- Fifth-generation Cephalosporin
  - By Type:
- Branded Cephalosporin Drugs
- Generic Cephalosporin Drugs
  - By Formulation:
- Oral
Tablets
Capsules
Liquid
- Injection
  - By Indication:
- Respiratory Tract Infection
- Skin Infection
- Ear Infection
- Bacterial Infection
- Urinary Tract Infection
- Sexually Transmitted Infection
- Sinus Infection
- Surgical Prophylaxis
- Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
  - By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Company Profiles
- Merck & Co. Inc.*
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GlaxoSmithKline plc.
- Pfizer Inc.
- Allergan plc.
- Abbott Laboratories
- Basilea Pharmaceutica Ltd.
- Sanofi S.A.
- F. Hoffmann-La Roche AG
- Lupin Limited
- Teva Pharmaceutical Industries Ltd.
- B. Braun Melsungen AG

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Generation
- Market Snippet, By Type
- Market Snippet, By Formulation
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Major Brand Analysis
Reimbursement Scenario
Epidemiology Analysis
Porter's Five Forces Model
Pipeline Analysis
Switch Analysis
Site Chain Analysis

4. Global Cephalosporin Drugs Market

Antibiotic Resistance Trends By Country

5. Global Cephalosporin Drugs Market, By Generation, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
First-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Second-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Third-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Fourth-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Fifth-generation Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Cephalosporin Drugs Market, By Type, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Branded Cephalosporin Drugs
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Generic Cephalosporin Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

7. Global Cephalosporin Drugs Market, By Formulation, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Oral
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Tablets
- Capsules
- Liquid
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Cephalosporin Drugs Market, By Indication, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Respiratory Tract Infection
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Skin Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Ear Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Bacterial Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Urinary Tract Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Sexually Transmitted Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Sinus Infection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Surgical Prophylaxis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Others (Meningitis, Acute Abdomen Infection, and Pelvic Infection)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

9. Global Cephalosporin Drugs Market, By Distribution Channel, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

10. Global Cephalosporin Drugs Market, By Region, 2017 - 2028, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, By Region, 2017 - 2028
- Regional Trends
North America
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
Europe
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
Asia Pacific
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Africa
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country/Region, 2017 - 2028, (US$ Million)
- North Africa
- Central Africa
- South Africa
Middle East
- Market Size and Forecast, By Generation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Formulation, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- GCC Countries
- Israel
- Rest of Middle East

11. Competitive Landscape

Company Profiles
- Merck & Co. Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Allergan plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Basilea Pharmaceutica Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F. Hoffmann-La Roche AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Lupin Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
Analyst Views

12. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

头孢菌素药的市场规模、占有率、趋势、预测 (2022年～2028年):各世代、类型、製剂、适应症、流通管道、地区

Cephalosporin Drugs Market, By Generation, By Type, By Formulation, By Indication, By Distribution Channel, and By Region - Size, Share, Trends, and Forecast, 2022 - 2028

目录

第1章调查目的、前提条件

第2章市场概要

第3章市场动态、法律规章、趋势分析

第4章全球头孢菌素药市场

第5章全球头孢菌素药市场:各世代

第6章全球头孢菌素药市场:各类型

第7章全球头孢菌素药市场:各製剂

第8章全球头孢菌素药市场:各适应症

第9章全球头孢菌素药市场:各流通管道

第10章全球头孢菌素药市场:各地区

第11章竞争情形

第12章 Section